MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ccd.29749

Медицинская библиотека · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2021

Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitation.

Lim D Scott, Smith Robert L, Zahr Firas, Dhoble Abhijeet, Laham Roger, Lazkani Mohamad, Kodali Susheel, Kliger Chad, Hermiller James, Vora Amit, Sarembock Ian J, Gray William, Kapadia Samir, Greenbaum Adam, Rassi Andrew, Lee David, Chhatriwalla Adnan, Shah Pinak, Rodés-Cabau Josep, Ibrahim Homam, Satler Lowell, Herrmann Howard C, Mahoney Paul, Davidson Charles, Petrossian George, Guerrero Mayra, Koulogiannis Konstantinos, Marcoff Leo, Gillam Linda, CLASP IID Pivotal Trial Investigators

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVES

We report the 30-day outcomes from the roll-in cohort of the CLASP IID trial, representing the first procedures performed by each site.

BACKGROUND

The currently enrolling CLASP IID/IIF pivotal trial is a multicenter, prospective, randomized trial assessing the safety and effectiveness of the PASCAL transcatheter valve repair system in patients with clinically significant MR. The trial allows for up to three roll-in patients per site.

METHODS

Eligibility criteria were: DMR ≥3+, prohibitive surgical risk, and deemed suitable for transcatheter repair by the local heart team. Trial oversight included a central screening committee and echocardiographic core laboratory. The primary safety endpoint was a 30-day composite MAE: cardiovascular mortality, stroke, myocardial infarction (MI), new need for renal replacement therapy, severe bleeding, and non-elective mitral valve re-intervention, adjudicated by an independent clinical events committee. Thirty-day echocardiographic, functional, and quality of life outcomes were assessed.

RESULTS

A total of 45 roll-in patients with mean age of 83 years and 69% in NYHA class III/IV were treated. Successful implantation was achieved in 100%. The 30-day composite MAE rate was 8.9% including one cardiovascular death (2.2%) due to severe bleeding from a hemorrhagic stroke, one MI, and no need for re-intervention. MR≤1+ was achieved in 73% and ≤2+ in 98% of patients. 89% of patients were in NYHA class I/II (p < .001) with improvements in 6MWD (30 m; p = .054) and KCCQ (17 points; p < .001).

CONCLUSIONS

Early results representing sites with first experience with the PASCAL repair system showed favorable 30-day outcomes in patients with DMR≥3+ at prohibitive surgical risk.

Для цитирования: Lim D Scott, Smith Robert L, Zahr Firas, Dhoble Abhijeet, Laham Roger, Lazkani Mohamad, Kodali Susheel, Kliger Chad, Hermiller James, Vora Amit, Sarembock Ian J, Gray William, Kapadia Samir, Greenbaum Adam, Rassi Andrew, Lee David, Chhatriwalla Adnan, Shah Pinak, Rodés-Cabau Josep, Ibrahim Homam, Satler Lowell, Herrmann Howard C, Mahoney Paul, Davidson Charles, Petrossian George, Guerrero Mayra, Koulogiannis Konstantinos, Marcoff Leo, Gillam Linda, CLASP IID Pivotal Trial Investigators. Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitation.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2021. DOI: 10.1002/ccd.29749.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.